H. B. Fuller/$FUL

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About H. B. Fuller

H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives and Construction Adhesives. It generates the maximum revenue from hygiene, health and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based and solvent-based products for applications in various markets, including packaging , converting, nonwoven and hygiene (disposable diapers, feminine care and medical garments) and health and beauty. The company generates around half of its revenue in the United States.

Ticker

$FUL
Sector

Primary listing

NYSE

Industry

Chemicals

Employees

7,500

ISIN

US3596941068

H. B. Fuller Metrics

BasicAdvanced
$3.3B
33.71
$1.84
1.11
$0.90
1.52%

What the Analysts think about H. B. Fuller

Analyst ratings (Buy, Hold, Sell) for H. B. Fuller stock.

Bulls say / Bears say

H.B. Fuller's acquisition of HS Butyl Limited, the UK's largest manufacturer of high-quality butyl tapes, expands its position in the global waterproofing tape market, potentially driving revenue growth. (marketscreener.com)
The company reported a 7% year-on-year increase in adjusted EPS to $1.13 in Q3 2024, indicating strong financial performance. (marketscreener.com)
Baird upgraded H.B. Fuller to 'Outperform' with a price target of $60, reflecting positive analyst sentiment. (marketscreener.com)
JP Morgan downgraded H.B. Fuller to 'Underweight' and reduced the price target to $50, citing weak performance in the Health, Hygiene, and Consumable segment. (benzinga.com)
The company reported a 2.7% year-over-year decline in net revenue in Q1 2025, indicating potential challenges in maintaining sales growth. (benzinga.com)
H.B. Fuller's Health, Hygiene, and Consumable segment's EBITDA dropped by 25% in Q1 2025, continuing a trend of weakness. (benzinga.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jun 2025.

H. B. Fuller Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

H. B. Fuller Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $FUL

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs